Martin Patricia A.

Martin Patricia A. is listed in filings as Director at AN2 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 10, 2026, including 19 public disclosures. Recent filings connect the profile to AN2 Therapeutics, Inc. (ANTX) and Cypherpunk Technologies Inc. (CYPH). The current snapshot covers public activity from Jun 21, 2024 to Apr 10, 2026. Reported amounts are shown as $179.1K to $140.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.